Managing cancer and living meaningfully (CALM): Implementation in Dutch cancer care.

anxiety cancer depression oncology palliative care psychotherapy

Journal

Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524

Informations de publication

Date de publication:
Jan 2024
Historique:
revised: 29 11 2023
received: 31 08 2023
accepted: 17 12 2023
medline: 29 1 2024
pubmed: 29 1 2024
entrez: 28 1 2024
Statut: ppublish

Résumé

Managing Cancer and Living Meaningfully (CALM) is a brief, evidence-based psychotherapy tailored for patients with advanced cancer that has not yet been implemented routinely in Dutch cancer care. The aim of this study was to assess the feasibility, acceptability, sustainability and effectiveness of CALM in different clinical settings in the Netherlands. In 2019 and 2020 a multi-center, intervention-only study was performed in three Dutch cancer care settings. Professionals were trained to provide CALM under supervision. Patients diagnosed with advanced cancer were included and filled out questionnaires to measure depression (Patient Health Questionnaire-9), death anxiety (Death and Dying Distress Scale), and anxiety (hospital anxiety and depression scale-anxiety) at baseline, 3 and 6 months. The Clinical Evaluation Questionnaire was used to assess acceptability of CALM at 3 and 6 months. Sixty-four patients (55% of the eligible patients) were included in the study and 85% of the included patients received 3 or more CALM sessions. Of the 24 trained therapists, 15 (63%) started providing CALM. Two years post-study, CALM was provided in each center by a total of 19 therapists. On average, patients perceived CALM to be at least somewhat helpful. A significant decrease in severity of depression (p = 0.006), death anxiety (p = 0.008), and anxiety (p = 0.024) was observed over time. This study shows that CALM therapy is feasible, acceptable, and sustainable in three Dutch cancer care settings, although not all predefined feasibility criteria for therapists were met. CALM can be effective in decreasing feelings of depression, anxiety, and death anxiety in patients with advanced cancer.

Identifiants

pubmed: 38282218
doi: 10.1002/pon.6281
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e6281

Subventions

Organisme : Roparun

Informations de copyright

© 2023 John Wiley & Sons Ltd.

Références

Lo C, Zimmermann C, Rydall A, et al. Longitudinal study of depressive symptoms in patients with metastatic gastrointestinal and lung cancer. J Clin Oncol. 2010;28(18):3084-3089. https://doi.org/10.1200/jco.2009.26.9712
Walker J, Holm Hansen C, Martin P, et al. Prevalence of depression in adults with cancer: a systematic review. Ann Oncol. 2013;24(4):895-900. https://doi.org/10.1093/annonc/mds575
Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160-174. https://doi.org/10.1016/s1470-2045(11)70002-x
Hotopf M, Chidgey J, Addington-Hall J, Ly KL. Depression in advanced disease: a systematic review Part 1. Prevalence and case finding. Palliat Med. 2002;16(2):81-97. https://doi.org/10.1191/0269216302pm507oa
Mehnert A, Vehling S, Hocker A, Lehmann C, Koch U. Demoralization and depression in patients with advanced cancer: validation of the German version of the demoralization scale. J Pain Sympt Manag. 2011;42(5):768-776. https://doi.org/10.1016/j.jpainsymman.2011.02.013
Hart NH, Crawford-Williams F, Crichton M, et al. Unmet supportive care needs of people with advanced cancer and their caregivers: a systematic scoping review. Crit Rev Oncol Hematol. 2022;176:103728. https://doi.org/10.1016/j.critrevonc.2022.103728
Bultz BD, Groff SL, Fitch M, et al. Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practice. Psycho Oncol. 2011;20(5):463-469. https://doi.org/10.1002/pon.1932
Rodin G, Lo C, Rydall A, et al. Managing cancer and living meaningfully (CALM): a randomized controlled trial of a psychological intervention for patients with advanced cancer. J Clin Oncol. 2018;36(23):2422-2432. https://doi.org/10.1200/jco.2017.77.1097
Zwanenburg LC, Suijkerbuijk KPM, van Dongen SI, et al. Living in the twilight zone: a qualitative study on the experiences of patients with advanced cancer obtaining long-term response to immunotherapy or targeted therapy. J Cancer Surviv. 2022. https://doi.org/10.1007/s11764-022-01306-9
Nissim R, Freeman E, Lo C, et al. Managing Cancer and Living Meaningfully (CALM): a qualitative study of a brief individual psychotherapy for individuals with advanced cancer. Palliat Med. 2012;26(5):713-721. https://doi.org/10.1177/0269216311425096
Lo C, Hales S, Jung J, et al. Managing Cancer and Living Meaningfully (CALM): phase 2 trial of a brief individual psychotherapy for patients with advanced cancer. Palliat Med. 2014;28(3):234-242. https://doi.org/10.1177/0269216313507757
Lo C, Hales S, Chiu A, et al. Managing Cancer and Living Meaningfully (CALM): randomised feasibility trial in patients with advanced cancer. BMJ Support Palliat Care. 2019;9(2):209-218. https://doi.org/10.1136/bmjspcare-2015-000866
Mehnert A, Koranyi S, Philipp R, et al. Efficacy of the Managing Cancer and Living Meaningfully (CALM) individual psychotherapy for patients with advanced cancer: a single-blind randomized controlled trial. Psycho Oncol. 2020;29(11):1895-1904. https://doi.org/10.1002/pon.5521
Koranyi S, Philipp R, Quintero Garzon L, et al. Testing the treatment integrity of the managing cancer and living meaningfully psychotherapeutic intervention for patients with advanced cancer. Front Psychol. 2020;11:561997. https://doi.org/10.3389/fpsyg.2020.561997
Rankin NM, Butow PN, Hack TF, et al. An implementation science primer for psycho-oncology: translating robust evidence into practice. J Psychosoc Oncol Res Pract. 2019;1(3):e14. https://doi.org/10.1097/or9.0000000000000014
Rodin G. From evidence to implementation: the global challenge for psychosocial oncology. Psycho Oncol. 2018;27(10):2310-2316. https://doi.org/10.1002/pon.4837
Caruso R, Sabato S, Nanni MG, et al. Application of managing cancer and living meaningfully (CALM) in advanced cancer patients: an Italian pilot study. Psychother Psychosom. 2020;89(6):402-404. https://doi.org/10.1159/000505875
Loughan AR, Willis KD, Braun SE, et al. Managing cancer and living meaningfully (CALM) in adults with malignant glioma: a proof-of-concept phase IIa trial. J Neuro Oncol. 2022;157(3):447-456. https://doi.org/10.1007/s11060-022-03988-8
Miyamoto S, Yamazaki T, Shimizu K, et al. Brief, manualised and semistructured individual psychotherapy programme for patients with advanced cancer in Japan: study protocol for Managing Cancer and Living Meaningfully (CALM) phase 2 trial. BMJ Open. 2022;12(3):e056136. https://doi.org/10.1136/bmjopen-2021-056136
Lynch FA, Rodin G, Jefford M, et al. Evaluation of Managing Cancer and Living Meaningfully (CALM) in people with advanced non-small cell lung cancer treated with immunotherapies or targeted therapies: protocol for a single-arm, mixed-methods pilot study. BMJ Open. 2023;13(7):e072322. https://doi.org/10.1136/bmjopen-2023-072322
Asnaani A, Benhamou K, Kaczkurkin AN, Turk-Karan E, Foa EB. Beyond the constraints of an RCT: naturalistic treatment outcomes for anxiety-related disorders. Behav Ther. 2020;51(3):434-446. https://doi.org/10.1016/j.beth.2019.07.007
Rodin G, Hales S. Managing Cancer and Living Meaningfully: The Paradox of Advanced Disease. Oxford University Press; 2021.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
Shapiro GK, Mah K, Li M, Zimmermann C, Hales S, Rodin G. Validation of the death and dying distress scale in patients with advanced cancer. Psycho Oncol. 2021;30(5):716-727. https://doi.org/10.1002/pon.5620
Tong E, Deckert A, Gani N, et al. The meaning of self-reported death anxiety in advanced cancer. Palliat Med. 2016;30(8):772-779. https://doi.org/10.1177/0269216316628780
Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997;27(2):363-370. https://doi.org/10.1017/s0033291796004382
de Vries FE, Mah K, Malfitano C, et al. Clinical evaluation questionnaire in advanced cancer: a psychometric study of a novel measure of healthcare provider interactions. BMJ Support Palliat Care. 2022: bmjspcare-2021-003408. https://doi.org/10.1136/bmjspcare-2021-003408
Lo C, Hales S, Rydall A, et al. Managing Cancer and Living Meaningfully: study protocol for a randomized controlled trial. Trials. 2015;16(1):391. https://doi.org/10.1186/s13063-015-0811-1
Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Pol Ment Health. 2011;38(2):65-76. https://doi.org/10.1007/s10488-010-0319-7
Twisk J, de Boer M, de Vente W, Heymans M. Multiple imputation of missing values was not necessary before performing a longitudinal mixed-model analysis. J Clin Epidemiol. 2013;66(9):1022-1028. https://doi.org/10.1016/j.jclinepi.2013.03.017
Dilworth S, Higgins I, Parker V, Kelly B, Turner J. Patient and health professional's perceived barriers to the delivery of psychosocial care to adults with cancer: a systematic review. Psycho Oncol. 2014;23(6):601-612. https://doi.org/10.1002/pon.3474
Fernandez-Gonzalez L, Namias MR, Bravo P. Facilitators and barriers perceived by health professionals in the implementation of Managing Cancer and Living Meaningfully (CALM) psychotherapy in Santiago. Ecancermedicalscience. 2021;15:1256. https://doi.org/10.3332/ecancer.2021.1256
Pini S, Hackett J, Taylor S, et al. Patient and professional experiences of palliative care referral discussions from cancer services: a qualitative interview study. Eur J Cancer Care. 2021;30(1):e13340. https://doi.org/10.1111/ecc.13340

Auteurs

Marianne Kool (M)

Center for Quality of Life, Antoni van Leeuwenhoek -Netherlands Cancer Institute, Amsterdam, the Netherlands.

Emma Hafkamp (E)

Center for Quality of Life, Antoni van Leeuwenhoek -Netherlands Cancer Institute, Amsterdam, the Netherlands.

Janna Gol (J)

Centre of Expertise in Palliative Care, University Medical Center Groningen (UMCG), University of Groningen, Groningen, the Netherlands.

Eline J Aukema (EJ)

Ingeborg Douwes Centrum (IDC), Centre of Expertise in Psycho-Oncology, OLVG, Amsterdam, the Netherlands.

Carmine Malfitano (C)

Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.

An Reyners (A)

Centre of Expertise in Palliative Care, University Medical Center Groningen (UMCG), University of Groningen, Groningen, the Netherlands.

Sarah Hales (S)

Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.

Lonneke van de Poll (L)

Psychosocial Research and Epidemiology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, the Netherlands.
Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.
Department of Medical and Clinical Psychology, Center of Research on Psychological and Somatic Disorders (CoRPS), Tilburg University, Tilburg, the Netherlands.

Gary Rodin (G)

Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.

Froukje de Vries (F)

Department of Psychiatry, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, the Netherlands.

Classifications MeSH